Latest News and Press Releases

ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights

ONWARD® Medical Publishes Annual Sustainability Summary

ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty...

ONWARD® Medical Announces Participation in Stifel European Healthcare Summit

ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference

ONWARD® Medical Announces Results of Annual General Meeting of Shareholders: shareholders approve all proposed resolutions

Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Einreichung des De-Novo-Antrags für das ARC-EX®-System bei der FDA  Erfolgreiche Einwerbung von 20 Mio. EUR an Eigenkapital ...

La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande...

ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights